p53 regulates metanephric development

Journal of the American Society of Nephrology

Volumn 20, Issue 11, 2009, Pages 2328-2337

  Saifudeen, Zubaida ^a   Dipp, Susana ^a   Stefkova, Jana ^a   Yao, Xiao ^a   Lookabaugh, Sarah ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; TRANSCRIPTION FACTOR PAX3;

ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GROWTH REGULATION; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; URINARY TRACT MALFORMATION;

ANIMALS; GENE EXPRESSION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; KIDNEY; MICE; ORGANOGENESIS; TUMOR SUPPRESSOR PROTEIN P53; WOLFFIAN DUCTS;

EID: 72049101514     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008121224     Document Type: Article

References (64)

1. Costantini F, Shakya R: GDNF/Ret signaling and the development of the kidney. Bioessays 28: 117-127, 2006
2. Davies JA: Morphogenesis of the metanephric kidney. ScientificWorldJournal 2: 1937-1950, 2002
3. Dressler GR: The cellular basis of kidney development. Annu Rev Cell Dev Biol 22: 509-529, 2006
4. Towers PR, Woolf AS, Hardman P: Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp Nephrol 6: 337-351, 1998 (Pubitemid 28338193)
5. Herzlinger D: Inductive interactions during kidney development. Semin Nephrol 15: 255-262, 1995
6. Shakya R, Jho EH, Kotka P, Wu Z, Kholodilov N, Burke R, D'Agati V, Costantini F: The role of GDNF in patterning the excretory system. Dev Biol 283: 70-84, 2005 (Pubitemid 40828843)
7. Tang MJ, Worley D, Sanicola M, Dressler GR: The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells. J Cell Biol 142: 1337-1345, 1998 (Pubitemid 28429114)
8. Kim D, Dressler GR: PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney. Dev Biol 307: 290-299, 2007 (Pubitemid 47007686)
9. Hellmich HL, Kos L, Cho ES, Mahon KA, Zimmer A: Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 54: 95-105, 1996 (Pubitemid 26043176)
10. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A: Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79, 1996 (Pubitemid 26243361)
11. Pepicelli CV, Kispert A, Rowitch DH, McMahon AP: GDNF induces branching and increased cell proliferation in the ureter of the mouse. Dev Biol 192: 193-198, 1997 (Pubitemid 28015657)
12. Maeshima A, Vaughn DA, Choi Y, Nigam SK: Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct. Dev Biol 295: 473-485, 2006 (Pubitemid 43927690)
13. Grieshammer U, Le M, Plump AS, Wang F, Tessier-Lavigne M, Martin GR: SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell 6: 709-917, 2004 (Pubitemid 38579353)
14. Kume T, Deng K, Hogan BL: Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development 127: 1387-1395, 2000 (Pubitemid 30232590)
15. Basson MA, Akbulut S, Watson-Johnson J, Simon R, Carroll TJ, Shakya R, Gross I, Martin GR, Lufkin T, McMahon AP, Wilson PD, Costantini FD, Mason IJ, Licht JD: Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 8: 229-239, 2005 (Pubitemid 40197739)
16. Hohenfellner K, Hunley TE, Schloemer C, Brenner W, Yerkes E, Zepp F, Brock JW 3rd, Kon V: Angiotensin type 2 receptor is important in the normal development of the ureter. Pediatr Nephrol 13: 187-191, 1999 (Pubitemid 29204555)
17. Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I: Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 105: 863-873, 2000 (Pubitemid 30203059)
18. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ: Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14: 981-993, 2000 (Pubitemid 30253006)
19. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR: High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 5: 931-936, 1995
20. Baatout S, Jacquet P, Michaux A, Buset J, Vankerkom J, Derradji H, Yan J, von Suchodoletz H, de Saint-Georges L, Desaintes C, Mergeay M: Developmental abnormalities induced by X-irradiation in p53 deficient mice. In Vivo 16: 215-221, 2002 (Pubitemid 34884496)
21. Fulci G, Van Meir EG: p53 and the CNS: Tumors and developmental abnormalities. Mol Neurobiol 19: 61-77, 1999 (Pubitemid 29174241)
22. Harvey M, McArthur MJ, Montgomery CA Jr, Bradley A, Donehower LA: Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J 7: 938-943, 1993 (Pubitemid 23225552)
23. Ikeda S, Hawes NL, Chang B, Avery CS, Smith RS, Nishina PM: Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice. Invest Ophthalmol Vis Sci 40: 1874-1878, 1999
24. Ohyama K, Chung CH, Chen E, Gibson CW, Misof K, Fratzl P, Shapiro IM: p53 influences mice skeletal development. J Craniofac Gen Dev Biol 17: 161-171, 1997 (Pubitemid 28045975)
25. Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, Shouval D, Galun E: p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 75: 2420-2426, 1995
26. Amariglio F, Tchang F, Prioleau MN, Soussi T, Cibert C, Mechali M: A functional analysis of p53 during early development of Xenopus laevis. Oncogene 15: 2191-2199, 1997 (Pubitemid 27493908)
27. Wallingford JB, Seufert DW, Virta VC, Vize PD: p53 activity is essential for normal development in Xenopus. Curr Biol 7: 747-757, 1997 (Pubitemid 27441829)
28. Hoever M, Clement JH, Wedlich D, Montenarh M, Knochel W: Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene 9: 109-120, 1994 (Pubitemid 24020940)
29. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S: Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113: 301-314, 2003 (Pubitemid 36556113)
30. Saifudeen Z, Dipp S, El-Dahr SS: A role for p53 in terminal epithelial cell differentiation. J Clin Invest 109: 1021-1030, 2002 (Pubitemid 34408577)
31. Saifudeen Z, Dipp S, Fan H, El-Dahr SS: Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: Implications for terminal nephron differentiation. Am J Physiol 288: F899-F909, 2005 (Pubitemid 40569754)
32. Saifudeen Z, Marks J, Du H, El-Dahr SS: Spatial repression of PCNA by p53 during kidney development. Am J Physiol 283: F727-F733, 2002 (Pubitemid 35033960)
33. Poladia DP, Kish K, Kutay B, Hains D, Kegg H, Zhao H, Bates CM: Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme. Dev Biol 291: 325-339, 2006
34. Shaulian E, Zauberman A, Ginsberg D, Oren M: Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 12: 5581-5592, 1992
35. Michael L, Davies JA: Pattern and regulation of cell proliferation during murine ureteric bud development. J Anat 204: 241-255, 2004 (Pubitemid 38515142)
36. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW: Regulation of PTEN transcription by p53. Mol Cell 8: 317-325, 2001
37. Diggle CP, Pitt E, Harnden P, Trejdosiewicz LK, Southgate J: Role of p53 in the responses of human urothelial cells to genotoxic damage. Int J Cancer 93: 199-203, 2001 (Pubitemid 32574275)
38. Vousden KH: Outcomes of p53 activation: Spoilt for choice. J Cell Science 119: 5015-5020, 2006
39. Embree-Ku M, Boekelheide K: FasL deficiency enhances the development of tumors in p53+/- mice. Toxicol Pathol 30: 705-713, 2002 (Pubitemid 36015313)
40. Basson MA, Watson-Johnson J, Shakya R, Akbulut S, Hyink D, Costantini FD, Wilson PD, Mason IJ, Licht JD: Branching morphogenesis of the ureteric epithelium during kidney development is coordinated by the opposing functions of GDNF and Sprouty1. Dev Biol 299: 466-477, 2006 (Pubitemid 44740419)
41. Marose TD, Merkel CE, McMahon AP, Carroll TJ: Beta-catenin is necessary to keep cells of ureteric bud/Wolffian duct epithelium in a precursor state. Dev Biol 314: 112-126, 2008
42. Pedersen A, Skjong C, Shawlot W: Lim 1 is required for nephric duct extension and ureteric bud morphogenesis. Dev Biol 288: 571-581, 2005 (Pubitemid 41790763)
43. Fan H, Harrell JR, Dipp S, Saifudeen Z, El-Dahr SS: A novel pathological role of p53 in kidney development revealed by gene-environment interactions. Am J Physiol 288: F98-F107, 2005 (Pubitemid 40038681)
44. Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T: Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol Cancer Res 1: 1048-1057, 2003
45. Marques MR, Horner JS, Ihrie RA, Bronson RT, Attardi LD: Mice Lacking the p53/p63 target gene Perp are resistant to papilloma development. Cancer Res 65: 6551-6556, 2005
46. Rickard SM, Mummery RS, Mulloy B, Rider CC: The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: Importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1. Glycobiology 13: 419-426, 2003 (Pubitemid 36665416)
47. Rider CC: Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. Biochem Soc Trans 34: 458-460, 2006
48. Forsten-Williams K, Chu CL, Fannon M, Buczek-Thomas JA, Nugent MA: Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng 36: 2134-2148, 2008
49. Colombres M, Henríquez JP, Reig GF, Scheu J, Calderón R, Alvarez A, Brandan E, Inestrosa NC: Heparin activates Wnt signaling for neuronal morphogenesis. J Cell Physiol 216: 805-815, 2008
50. Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I: Tumor suppressor p53 regulates heparanase gene expression. Oncogene 25: 3939-3947, 2006 (Pubitemid 43990749)
51. Godley LA, Kopp JB, Eckhaus M, Paglino JJ, Owens J, Varmus HE: Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10: 836-850, 1996 (Pubitemid 26112431)
52. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA: Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7, 1994 (Pubitemid 2027671)
53. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A: Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29: 418-425, 2001 (Pubitemid 34326692)
54. Shao X, Somlo S, Igarashi P: Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1837-1846, 2002
55. Igarashi P, Shashikant CS, Thomson RB, Whyte DA, Liu-Chen S, Ruddle FH, Aronson PS: Ksp-cadherin gene promoter: II. Kidney-specific activity in transgenic mice. Am J Physiol 277: F599-F610, 1999 (Pubitemid 29526001)
56. Zhao H, Kegg H, Grady S, Truong HT, Robinson ML, Baum M, Bates CM: Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud. Dev Biol 276: 403-415, 2004 (Pubitemid 39592403)
57. Engleka KA, Gitler AD, Zhang M, Zhou DD, High FA, Epstein JA: Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. Dev Biol 280: 396-406, 2005 (Pubitemid 40692140)
58. Chang CP, McDill BW, Neilson JR, Joist HE, Epstein JA, Crabtree GR, Chen F: Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest 113: 1051-1058, 2004
59. Pachnis V, Mankoo B, Costantini F: Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005-1017, 1993 (Pubitemid 23358572)
60. Srinivas S, Wu Z, Chen CM, D'Agati V, Costantini F: Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. Development 126: 1375-1386, 1999 (Pubitemid 29195227)
61. Tang MJ, Cai Y, Tsai SJ, Wang YK, Dressler GR: Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase. Dev Biol 243: 128-136, 2002 (Pubitemid 34208408)
62. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al.: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
63. Golubovskaya V, Kaur A, Cance W: Cloning and characterization of the promoter region of human focal adhesion kinase gene: Nuclear factor kappa B and p53 binding sites. Biochim Biophys Acta 1678: 111-125, 2004 (Pubitemid 38626172)
64. Singh B, Reddy PG, Goberdhan A, Walsh C, Dao S, Ngai I, Chou TC, O-Charoenrat P, Levine AJ, Rao PH, Stoffel A: p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 16: 984-993, 2002 (Pubitemid 34408547)